Inventor · disambiguated record
Lakmal Boteju
Also filed as: BOTEJU LAKMAL · BOTEJU LAKMAL W
7 granted patents·10 pending applications·29 citations·filing 2002–2020
80Inventor score
Files withRAFAEL PHARMACEUTICALS INC6AUGERI DAVID J2BLACKBURN THOMAS P1CORNERSTONE PHARMACEUTICALS INC1LEXICON PHARMACEUTICALS INC1
Top patents by PatentIndex Score
17 records- 0192US7649098B2Imidazole-based compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2007·Granted Jan 19, 2010·20 cites·15 claims
- 0277US8404732B2Methods of treating ulcerative colitisAUGERI DAVID J·Filed 2012·Granted Mar 26, 2013·3 cites·14 claims
- 0377US7465750B2Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methodsLUNDBECK & CO AS H·Filed 2006·Granted Dec 16, 2008·4 cites·16 claims
- 0474US8093267B2Methods of treating rheumatoid arthritisAUGERI DAVID J·Filed 2009·Granted Jan 10, 2012·1 cites·5 claims
- 0571US10179796B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Jan 15, 2019·1 cites·24 claims
- 0664US2020331931A1Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0760US2018273551A1Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0860US2009318504A1Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsBLACKBURN THOMAS P·Filed 2008·Application pending·0 cites
- 0957US2015322103A1Pharmaceutical compoundsCORNERSTONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1055US10526357B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2018·Granted Jan 7, 2020·0 cites·18 claims
- 1149US2022040133A1Oral therapy using 6,8-bis-benzylthio-octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1248US2003176314A1Compounds for the treatment of painFiled 2002·Application pending·0 cites
- 1348US2003139431A1Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptorsFiled 2002·Application pending·0 cites
- 1447US2004127502A1Use of GAL3 antagonist for treatment of depressionSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 1544US10450337B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·0 cites·25 claims
- 1637US2003144310A1Molecules specific for NPFF receptors and uses thereofFiled 2002·Application pending·0 cites
- 1732US2003078271A1Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →